Tower Research Capital (TRC)’s Kindred Healthcare KND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-2,607
Closed -$23K 4613
2018
Q2
$23K Sell
2,607
-1,462
-36% -$13.1K ﹤0.01% 2370
2018
Q1
$37K Buy
+4,069
New +$37.6K ﹤0.01% 1859
2017
Q4
Sell
-680
Closed -$5K 4393
2017
Q3
$5K Sell
680
-1,543
-69% -$13.1K ﹤0.01% 3358
2017
Q2
$26K Buy
+2,223
New +$21.9K ﹤0.01% 1094
2017
Q1
Sell
-5,571
Closed -$43K 4429
2016
Q4
$43K Buy
+5,571
New +$45.7K ﹤0.01% 1539
2015
Q4
Sell
-6,606
Closed -$104K 5436
2015
Q3
$104K Buy
6,606
+4,012
+155% +$81.2K 0.01% 545
2015
Q2
$53K Buy
+2,594
New +$59.4K ﹤0.01% 1318
2014
Q4
Sell
-8,195
Closed -$162K 5099
2014
Q3
$159K Buy
+8,195
New +$179K 0.02% 627
2014
Q2
Sell
-7,384
Closed -$173K 4974
2014
Q1
$173K Buy
7,384
+3,596
+95% +$74.4K 0.02% 460
2013
Q4
$75K Buy
3,788
+3,060
+420% +$49.3K 0.01% 1045
2013
Q3
$10K Buy
+728
New +$10.5K ﹤0.01% 3232

Tower Research Capital (TRC)'s KND Position: Q3 2018 in Review

Tower Research Capital (TRC) sold out of Kindred Healthcare (KND) in Q3 2018, closing a stake of 2,607 shares — an estimated $23K sold.

Tower Research Capital (TRC) first reported a position in KND in Q3 2013 and held it in 11 quarters. The position peaked at $173K in Q1 2014. 0 funds tracked by Wall St. Rank hold KND as of Q3 2018.

  • Tower Research Capital (TRC) reported no remaining Kindred Healthcare position as of Q3 2018 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 2,607 Kindred Healthcare shares in Q3 2018, an estimated $23K.
  • Tower Research Capital (TRC) first reported a position in Kindred Healthcare in Q3 2013 and held it in 11 quarters.
  • Tower Research Capital (TRC)'s Kindred Healthcare position peaked at $173K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held Kindred Healthcare as of Q3 2018.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2018, filed 13 Nov 2018.